Non-hormonal treatment for hot flashes is not a second-best option — several of these medications were tested in randomized trials against placebo and work. The newest are fezolinetant and elinzanetant, neurokinin receptor antagonists developed specifically for menopausal hot flashes, which block the brain pathway that triggers them without using any hormone. Older options with real evidence include SSRIs and SNRIs, gabapentin, oxybutynin, and cognitive behavioral therapy.
Who this is for
Women who cannot take estrogen — including breast cancer survivors and women with a history of blood clot or stroke
Women who could take estrogen but would rather not
Women whose hot flashes persist on hormone therapy, or who want to reduce their hormone dose
Women with bladder urgency needing medication alongside behavioral treatment
Women whose main problem is insomnia, where cognitive behavioral therapy has the strongest evidence of anything available
Why this page exists
Plenty of women are told that if they cannot take hormones, there is nothing to be done. That is out of date, and it was never quite true.
Hot flashes have a known mechanism. Falling estrogen removes restraint from KNDy neurons in the hypothalamus, which signal through neurokinin B onto the brain’s temperature control center and narrow the range of core temperature your body will tolerate. Fezolinetant and elinzanetant were built by targeting that pathway directly. They are not repurposed medications used on a hunch; they went through phase 3 trials for this indication and were approved for it.
The older options — SSRIs, SNRIs, gabapentin, oxybutynin — were discovered to help hot flashes and then tested properly. Their effects are smaller than estrogen’s, but they are real, and for a woman who has had breast cancer or a blood clot, they are what is available and they work.
How we choose
We start with what else is going on. If you also have depression or anxiety, an SNRI or SSRI does two jobs. If night sweats dominate, gabapentin at bedtime is often the most useful. If you have bladder urgency too, oxybutynin can address both, though we weigh anticholinergic burden carefully over 65. If you take tamoxifen, we avoid paroxetine and fluoxetine entirely.
If you want the most effective non-hormonal option for hot flashes specifically, that is usually a neurokinin antagonist. Fezolinetant requires liver monitoring, and we set up that schedule before you start rather than after.
Cost and coverage are part of the conversation, not an afterthought. The newer agents are expensive and coverage varies. We check before you leave and we handle prior authorization.
Measuring whether it worked
Every option gets a defined trial — usually 8 to 12 weeks — and a way to measure the result. You log hot flash frequency and a symptom score in the app. At the end of the trial we compare numbers, not impressions.
If it did not work, we say so and change it. Most women who are not helped by the first non-hormonal option are helped by a second one. Cycling through medications without measuring anything is how people end up on four prescriptions that are not doing much.
Options
Non-hormonal options we prescribe, and what each is actually for.
Option
How it is taken
Typical use
Fezolinetant
An oral tablet once a day
FDA-approved for moderate to severe hot flashes. Blocks the neurokinin 3 receptor. Liver blood tests are checked before starting and periodically after.
Elinzanetant
An oral capsule once a day
A dual neurokinin 1 and 3 receptor antagonist for moderate to severe hot flashes, with trial data also showing improvement in sleep disturbance.
Paroxetine 7.5 mg
An oral capsule at bedtime
The only non-hormonal product FDA-approved for hot flashes at this dose. Not used with tamoxifen, because it interferes with tamoxifen activation.
Venlafaxine or escitalopram
An oral tablet once a day
Off-label for hot flashes with good trial support. A sensible choice when low mood or anxiety needs treating as well.
Gabapentin
An oral capsule, usually at bedtime
Off-label. Particularly useful when night sweats are the dominant problem, since it is sedating.
Oxybutynin
An oral tablet
Off-label for hot flashes with randomized trial support. Also used for bladder urgency. Anticholinergic burden is weighed, especially in older women.
Mirabegron or vibegron
An oral tablet once a day
Beta-3 agonists for bladder urgency. No anticholinergic effect, which is why they are often preferred in older women.
Cognitive behavioral therapy
Weekly sessions, in person or through a digital program
Reduces how much hot flashes bother you and improves insomnia. The benefit for insomnia outlasts treatment, which no sleep medication can claim.
What the evidence supports
Each claim below carries a rating. Strong means randomized trials and current
specialty guidelines support it. Moderate means the evidence is real but has
meaningful limits. Limited means early, small, or indirect evidence — and where we
say Limited, that is us telling you not to count on it.
Neurokinin receptor antagonists reduce hot flash frequency and severity
Evidence for Neurokinin receptor antagonists reduce hot flash frequency and severity:● Strong evidence
Fezolinetant and elinzanetant both reduced moderate to severe hot flash frequency and severity against placebo in phase 3 randomized trials, and both are FDA-approved for this indication. They are less effective than estrogen on average, but the effect is real and substantial.
SSRIs and SNRIs reduce hot flashes
Evidence for SSRIs and SNRIs reduce hot flashes:● Strong evidence
Multiple randomized trials support paroxetine, venlafaxine, escitalopram, and citalopram. Low-dose paroxetine is FDA-approved for this indication. Typical reductions are smaller than with estrogen but meaningful.
Gabapentin and oxybutynin reduce hot flashes
Evidence for Gabapentin and oxybutynin reduce hot flashes:● Moderate evidence
Both have randomized trial support and both are used off-label for this purpose. Side effects — sedation with gabapentin, dry mouth and anticholinergic burden with oxybutynin — drive the choice as much as efficacy does.
Cognitive behavioral therapy reduces hot flash bother and treats insomnia
Evidence for Cognitive behavioral therapy reduces hot flash bother and treats insomnia:● Strong evidence
CBT does not reliably reduce how many hot flashes you have; it reduces how much they interfere with your life, which is what most women actually want. For insomnia, CBT-I outperforms sleep medication and its benefit persists after treatment stops.
Supplements, herbals, and compounded products marketed as natural alternatives control hot flashes
Evidence for Supplements, herbals, and compounded products marketed as natural alternatives control hot flashes:● Limited evidence
Trials of black cohosh, evening primrose, and similar products have been small, inconsistent, and largely negative. They are not held to prescription manufacturing standards. We will not recommend them as treatment, and we do ask what you are taking because some interact with prescriptions.
Local therapy is a separate decision from systemic therapy, and often still available.
Common questions
How much less effective are these than hormone therapy?
+
For hot flashes, estrogen typically produces the largest reduction in randomized trials. The neurokinin antagonists come next, with SSRIs, SNRIs, and gabapentin producing smaller but real reductions. Averages are not the whole story — some women respond better to a non-hormonal option than the average would predict, and we adjust based on your symptom score rather than on what a trial mean says.
Are antidepressants only for women who are depressed?
+
No. At the doses used for hot flashes, these medications are being used for a different effect on the same neurotransmitter systems that influence temperature regulation. Low-dose paroxetine is FDA-approved specifically for hot flashes. If you also have low mood or anxiety, that is a reason to choose this class, not a requirement for using it.
What about black cohosh, soy, or evening primrose oil?
+
The trial evidence is weak and inconsistent, and results have not held up in larger studies. We do not recommend them as treatment. We do want to know if you are taking them, because some interact with prescription medications and supplements are not manufactured to prescription standards.
Can I combine a non-hormonal medication with vaginal estrogen?
+
Yes, and that combination is common. Treating hot flashes with a non-hormonal medication and treating genitourinary symptoms with low-dose vaginal estrogen are two separate decisions. Even women who cannot use systemic estrogen often can use local therapy.
Does methenamine work for preventing UTIs?
+
Methenamine hippurate has trial evidence supporting it as an alternative to daily antibiotic prophylaxis in some women with recurrent UTIs, including a non-inferiority trial in the UK. It works by acidifying urine to produce formaldehyde, so it needs adequate urine acidity to do anything. We use it selectively rather than routinely.
Medically reviewed by PLACEHOLDER — Medical Director, MD · Reviewed
· Updated PLACEHOLDER: replace with the reviewing clinician before launch.
Ready to talk to someone who treats this every day?
Insurance-based visits across metro Atlanta. No membership, no cash-pay program, no obligation to start hormones.